Chewing and swallowing in scleroderma patients
Part of Skin clinical trials.
This study looks at how scleroderma affects chewing and swallowing in children and adults. It aims to help understand these problems better so care can be improved.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with scleroderma.
- If you are a child, you must be between 7 and 18 years old.
- If you are an adult, you must be over 18 years old.
- You do not have advanced heart, lung, liver, or kidney disease, a neurological condition, or cancer.
- You have not been in a regular exercise program in the past 3 months.
- You are willing to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how scleroderma affects physical performance and daily function in children and adults. It aims to understand the impact of the disease on movement and everyday activities.
This study tests if a special exercise program based on your body and mind can help people with scleroderma feel better. It is for both children (ages 7-18) and adults.
This study is adapting a questionnaire to measure how scleroderma affects your daily life. Your responses will help make the tool more useful for Turkish-speaking patients.
This study tests whether a special diet can help reduce bloating and stomach discomfort in people with scleroderma (systemic sclerosis). You'll follow a specific meal plan to see if it improves your digestive symptoms.
This study follows adults with systemic scleroderma (also called scleroderma) to better understand the condition over time. You may be included if you meet specific diagnosis and blood-test requirements and can give informed consent.
If you have scleroderma and trouble with heartburn or regurgitation that doesn't improve with usual acid-reducing medicines, this study helps doctors understand why. The results could guide better treatments for your reflux symptoms.
Hear when a new Systemic Sclerosis (SSc) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.